Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Hypertension|March 14, 2007
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp, Zhongxin Zhang, Barry M Brenner, et al.Journal of the American College of Cardiology|September 6, 2005
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) studyEigil Fossum, Andreas Moan, Sverre E Kjeldsen, et al.Blood Pressure|December 17, 2009
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension studySverre E Kjeldsen, Richard B Devereux, Darcy A Hille, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|March 24, 2005
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE studySverre E Kjeldsen, Paulette A Lyle, Jorge R Kizer, et al.Hypertension (Dallas, Tex. : 1979)|March 26, 2005
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophyFrej Fyhrquist, Björn Dahlöf, Richard B Devereux, et al.JAMA|July 9, 2004
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trialMichael A Blazing, James A de Lemos, Harvey D White, et al.Hypertension (Dallas, Tex. : 1979)|December 8, 2004
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension studyJorge R Kizer, Björn Dahlöf, Sverre E Kjeldsen, et al.Annals of Internal Medicine|December 4, 2003
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE studyKristian Wachtell, Hans Ibsen, Michael H Olsen, et al.Pageof 3